Published on
Dr. Srdan Verstovsek, a world-renowned researcher from MD Anderson Cancer Center, explores what he describes as "unprecedented developments" in the understanding of myeloproliferative neoplasms (MPNs). Dr. Verstovsek explains how these developments could lead to more effective treatment options for people with essential thrombocythemia (ET), myelofibrosis (PMF) and polycythemia vera (PV).
View more programs featuring Srdan Verstovsek, MD, PhD
Produced in association with The University of Texas MD Anderson Cancer Center
Become a member to access our latest content and be the first to know about new programs and information.
Mike Harris choses to live a full life with myelofibrosis, continuing to hunt, fish and help support other patients learning to live with the challenges of having a chronic illness.
Published:
Over the past year, there has been continued progress in improving treatments for myelofibrosis. Watch now as Dr. Claire Harrison shares updated news from the Comfort II study, including how patients are responding to the treatment regimen with few side effects.
Published:
